N. Gupta et al., HYPOXIA-REOXYGENATION POTENTIATES ZYMOSAN ACTIVATED PLASMA-INDUCED ENDOTHELIAL INJURY, The Journal of surgical research (Print), 77(2), 1998, pp. 91-98
The pathophysiology of ischemia-reperfusion injury and the role played
by the interaction of plasma proteins, including complement, with rep
erfused endothelium remains incompletely understood. Venular endotheli
al changes due to hypoxia followed by reoxygenation (H-R) are vital be
cause venules are the primary site of fluid accumulation and polymorph
onuclear leukocyte deposition due to inflammation. This investigation
focused on whether H-R potentiates the response to permeability induci
ng agents found in activated plasma. Activated complement was studied
by using zymosan activated plasma (ZAP). Permeability changes were ass
essed by quantitating rate of clearance of albumin across the monolaye
rs. H-R alone did not change permeability relative to the normoxic con
dition, ZAP at 2% in normoxic cells increased albumin clearance from 2
+/- 0.2 to 9 +/- 1.0 mu L/h, which increased significantly to 13.5 +/
- 2.0 mu L/h when given to hypoxia-reoxygenation challenged monolayers
. The permeability response to ZAP was dose related and not present wi
th heat inactivated ZAP. ZAP at 2% altered the structure of the cytosk
eleton of the human umbilical vein endothelial cells (HUVEC). However,
addition of monoclonal anti-complement antibodies or addition of solu
ble complement receptor-1 did not attenuate ZAP-induced HUVEC permeabi
lity. Addition of zymosan-activated serum did not alter the permeabili
ty and addition of heparin inhibited the ZAP-induced changes in permea
bility, suggesting that these changes were mediated via thrombin and n
ot complement. The increase in monolayer permeability due to ZAP was p
revented by increasing intracellular adenosine-3',5'-cyclic monophosph
ate, These findings suggest that HUVEC monolayers challenged with H-R
are more susceptible to increases in permeability induced by activated
plasma components. (C) 1998 Academic Press.